As hs-CRP has been classically linked to coronary events [14], it is also reasonable to address the role of IL-6, an even more precocious biomarker of inflammation than hs-CRP [15], in improving the detection of CAD and the severity of disease in this population. This evidence concerns the gene IL6 and coronary artery disorder.